Yuxi Ma

Biochemistry, Genetics and Molecular Biology · University of Michigan

Early career · publishing since 2018Rising activity

MicroRNA in disease regulation RNA modifications and cancer Cancer-related molecular mechanisms research Genomics, phytochemicals, and oxidative stress Cancer Cells and Metastasis

Publications

Citations

484

Est. group size

Recurring co-author estimate

Active years

Publishing since 2018

In context

Among 543 early career Biochemistry, Genetics and Molecular Biology PIs within our index

Citations: 484cohort median 176

Publications / year (recent): 3.2cohort median 2.4

Typically publishes in teams of ~8 · 0% small-team papers (≤3 authors) · across 14 venues

Publication cadence

Publications per year over the last 10 years — averaging 3.2/year recently

Collaborators per year

Distinct co-authors at University of Michigan each year — a rough indication of whether the group around this researcher has been growing or contracting. An estimate from co-authorship, not a roster: collaborators are not necessarily lab members, and recent years can be under-counted while indexing catches up.

Recent publications

Safety and efficacy of systemic chemotherapy plus PD-1 inhibitor in combination with intravenous or intraperitoneal bevacizumab in gastric cancer with peritoneal metastasis
BMC Cancer · 2025
Fn14-targeting, NIR-II responsive nanomaterials for enhanced radiotherapy against glioblastomas
Nanoscale Advances · 2025
First Report of Root-Knot Nematode ( Meloidogyne arenaria ) Infecting Vicia villosa var. glabrescens in China
Plant Disease · 2025
Neutrophil extracellular traps in cancer
MedComm · 2024
Extracellular vesicles in cancers: mechanisms, biomarkers, and therapeutic strategies
MedComm · 2024
Simultaneous Targeting of NQO1 and SOD1 Eradicates Breast Cancer Stem Cells via Mitochondrial Futile Redox Cycling
Cancer Research · 2024
Proposing and solving olympiad geometry with guided tree search
arXiv (Cornell University) · 2024
Abstract PO3-24-10: Losartan enhances the radiosensitivity of triple-negative breast cancer by reshaping the tumor immune microenvironment
Cancer Research · 2024
Supplementary Data from Simultaneous Targeting of NQO1 and SOD1 Eradicates Breast Cancer Stem Cells via Mitochondrial Futile Redox Cycling
2024
Data from Simultaneous Targeting of NQO1 and SOD1 Eradicates Breast Cancer Stem Cells via Mitochondrial Futile Redox Cycling
2024
Systemic treatments for breast cancer brain metastasis
Frontiers in Oncology · 2023
Icariside I – A novel inhibitor of the kynurenine-AhR pathway with potential for cancer therapy by blocking tumor immune escape
Biomedicine & Pharmacotherapy · 2022
Comprehensive analysis identifies as a critical prognostic prediction gene in breast cancer
Chinese Medical Journal · 2022
XIST Regulates Breast Cancer Stem Cells by Activating Proinflammatory IL-6 Signaling
Research Square · 2022
The Roles of the Let-7 Family of MicroRNAs in the Regulation of Cancer Stemness
Cells · 2021

Publishes in

MedComm×2
Cancer Research×2
Cells×1
Oncogene×1
Cell Metabolism×1

Similar researchers

By research-topic overlap

Gian Luca Rampioni Vinciguerra
Biochemistry, Genetics and Molecular Biology · The Ohio State University
Giovanni Nigita
Biochemistry, Genetics and Molecular Biology · The Ohio State University
Jing Liu
Biochemistry, Genetics and Molecular Biology · Purdue University West Lafayette
Jia Wang
Biochemistry, Genetics and Molecular Biology · Indiana University
Jing Chen
Biochemistry, Genetics and Molecular Biology · University of Michigan

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 25, 2026.

Claim or correct this profile